APO Research

APO RESEARCH · REPORT

lncRNA Sequencing Service

Selected research

Market Analysis & Forecast

Global lncRNA Sequencing Service Market Analysis and Forecast 2026-2032

Market perspective

The global lncRNA Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for lncRNA Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for lncRNA Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for lncRNA Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for lncRNA Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of lncRNA Sequencing Service include LC Sciences, Creative Biolabs, Eurofins Scientific, CD Genomics, Novogene Co, Ltd., Beijing Compass Biotechnology Co., Ltd., Biomarker Technologies, Azenta and BGI Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for lncRNA Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of lncRNA Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for lncRNA Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the lncRNA Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global lncRNA Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for lncRNA Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

lncRNA Sequencing Service Segment by Company

LC Sciences

Creative Biolabs

Eurofins Scientific

CD Genomics

Novogene Co, Ltd.

Beijing Compass Biotechnology Co., Ltd.

Biomarker Technologies

Azenta

BGI Genomics

Annoroad Gene Technology

lncRNA Sequencing Service Segment by Type

Normal-depth Sequencing

High-depth Sequencing

lncRNA Sequencing Service Segment by Application

Agriculture

Medical

lncRNA Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global lncRNA Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of lncRNA Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of lncRNA Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of lncRNA Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of lncRNA Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, lncRNA Sequencing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global lncRNA Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Normal-depth Sequencing Major Player Table 3. High-depth Sequencing Major Player Table 4. Global lncRNA Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Agriculture Major Player Table 6. Medical Major Player Table 7. lncRNA Sequencing Service Industry Trends Table 8. lncRNA Sequencing Service Industry Drivers Table 9. lncRNA Sequencing Service Industry Opportunities and Challenges Table 10. lncRNA Sequencing Service Industry Restraints Table 11. Global lncRNA Sequencing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global lncRNA Sequencing Service Market Size by Region (2021-2026) & (US$ Million) Table 13. Global lncRNA Sequencing Service Market Share by Region (2021-2026) Table 14. Global lncRNA Sequencing Service Market Size by Region (2027-2032) & (US$ Million) Table 15. Global lncRNA Sequencing Service Market Share by Region (2027-2032) Table 16. Global lncRNA Sequencing Service Revenue by Players (US$ Million) & (2021-2026) Table 17. Global lncRNA Sequencing Service Revenue Market Share by Players (2021-2026) Table 18. Global lncRNA Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global lncRNA Sequencing Service Key Players Headquarters & Area Served Table 20. Global lncRNA Sequencing Service Players, Product Type & Application Table 21. Global lncRNA Sequencing Service Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global lncRNA Sequencing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global lncRNA Sequencing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 26. Global lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 27. Global lncRNA Sequencing Service Revenue Market Share by Type (2021-2026) Table 28. Global lncRNA Sequencing Service Revenue Market Share by Type (2027-2032) Table 29. Global lncRNA Sequencing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 31. Global lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 32. Global lncRNA Sequencing Service Revenue Market Share by Application (2021-2026) Table 33. Global lncRNA Sequencing Service Revenue Market Share by Application (2027-2032) Table 34. LC Sciences Company Information Table 35. LC Sciences Business Overview Table 36. LC Sciences lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. LC Sciences lncRNA Sequencing Service Product Portfolio Table 38. LC Sciences Recent Development Table 39. Creative Biolabs Company Information Table 40. Creative Biolabs Business Overview Table 41. Creative Biolabs lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Creative Biolabs lncRNA Sequencing Service Product Portfolio Table 43. Creative Biolabs Recent Development Table 44. Eurofins Scientific Company Information Table 45. Eurofins Scientific Business Overview Table 46. Eurofins Scientific lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Eurofins Scientific lncRNA Sequencing Service Product Portfolio Table 48. Eurofins Scientific Recent Development Table 49. CD Genomics Company Information Table 50. CD Genomics Business Overview Table 51. CD Genomics lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. CD Genomics lncRNA Sequencing Service Product Portfolio Table 53. CD Genomics Recent Development Table 54. Novogene Co, Ltd. Company Information Table 55. Novogene Co, Ltd. Business Overview Table 56. Novogene Co, Ltd. lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Novogene Co, Ltd. lncRNA Sequencing Service Product Portfolio Table 58. Novogene Co, Ltd. Recent Development Table 59. Beijing Compass Biotechnology Co., Ltd. Company Information Table 60. Beijing Compass Biotechnology Co., Ltd. Business Overview Table 61. Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Product Portfolio Table 63. Beijing Compass Biotechnology Co., Ltd. Recent Development Table 64. Biomarker Technologies Company Information Table 65. Biomarker Technologies Business Overview Table 66. Biomarker Technologies lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Biomarker Technologies lncRNA Sequencing Service Product Portfolio Table 68. Biomarker Technologies Recent Development Table 69. Azenta Company Information Table 70. Azenta Business Overview Table 71. Azenta lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Azenta lncRNA Sequencing Service Product Portfolio Table 73. Azenta Recent Development Table 74. BGI Genomics Company Information Table 75. BGI Genomics Business Overview Table 76. BGI Genomics lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BGI Genomics lncRNA Sequencing Service Product Portfolio Table 78. BGI Genomics Recent Development Table 79. Annoroad Gene Technology Company Information Table 80. Annoroad Gene Technology Business Overview Table 81. Annoroad Gene Technology lncRNA Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Annoroad Gene Technology lncRNA Sequencing Service Product Portfolio Table 83. Annoroad Gene Technology Recent Development Table 84. North America lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 85. North America lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 86. North America lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 87. North America lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 88. North America lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America lncRNA Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 90. North America lncRNA Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe lncRNA Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe lncRNA Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 98. China lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 99. China lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 100. China lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 101. China lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia lncRNA Sequencing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia lncRNA Sequencing Service Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia lncRNA Sequencing Service Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA lncRNA Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA lncRNA Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA lncRNA Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA lncRNA Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA lncRNA Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA lncRNA Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. lncRNA Sequencing Service Image Figure 2. Global lncRNA Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global lncRNA Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Normal-depth Sequencing Image Figure 5. High-depth Sequencing Image Figure 6. Global lncRNA Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global lncRNA Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Agriculture Image Figure 9. Medical Image Figure 10. Global lncRNA Sequencing Service Market Size (US$ Million) & (2021-2032) Figure 11. Global lncRNA Sequencing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global lncRNA Sequencing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global lncRNA Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global lncRNA Sequencing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global lncRNA Sequencing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global lncRNA Sequencing Service Revenue Market Share by Type (2021-2032) Figure 18. Global lncRNA Sequencing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global lncRNA Sequencing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global lncRNA Sequencing Service Revenue Market Share by Application (2021-2032) Figure 21. North America lncRNA Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America lncRNA Sequencing Service Revenue Share by Type (2021-2032) Figure 23. North America lncRNA Sequencing Service Revenue Share by Application (2021-2032) Figure 24. North America lncRNA Sequencing Service Revenue Share by Country (2021-2032) Figure 25. United States lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe lncRNA Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe lncRNA Sequencing Service Revenue Share by Type (2021-2032) Figure 30. Europe lncRNA Sequencing Service Revenue Share by Application (2021-2032) Figure 31. Europe lncRNA Sequencing Service Revenue Share by Country (2021-2032) Figure 32. Germany lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China lncRNA Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China lncRNA Sequencing Service Revenue Share by Type (2021-2032) Figure 42. China lncRNA Sequencing Service Revenue Share by Application (2021-2032) Figure 43. Asia lncRNA Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia lncRNA Sequencing Service Revenue Share by Type (2021-2032) Figure 45. Asia lncRNA Sequencing Service Revenue Share by Application (2021-2032) Figure 46. Asia lncRNA Sequencing Service Revenue Share by Region (2021-2032) Figure 47. Japan lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA lncRNA Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA lncRNA Sequencing Service Revenue Share by Type (2021-2032) Figure 55. SAMEA lncRNA Sequencing Service Revenue Share by Application (2021-2032) Figure 56. SAMEA lncRNA Sequencing Service Revenue Share by Country (2021-2032) Figure 57. Brazil lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt lncRNA Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Normal-depth Sequencing
  • High-depth Sequencing
Applications
  • Agriculture
  • Medical
Companies covered
  • LC Sciences
  • Creative Biolabs
  • Eurofins Scientific
  • CD Genomics
  • Novogene Co, Ltd.
  • Beijing Compass Biotechnology Co., Ltd.
  • Biomarker Technologies
  • Azenta
  • BGI Genomics
  • Annoroad Gene Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 lncRNA Sequencing Service Market by Type
  3. 1.2.1 Global lncRNA Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Normal-depth Sequencing
  5. 1.2.3 High-depth Sequencing
  6. 1.3 lncRNA Sequencing Service Market by Application
  7. 1.3.1 Global lncRNA Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Agriculture
  9. 1.3.3 Medical
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 lncRNA Sequencing Service Market Dynamics
  1. 2.1 lncRNA Sequencing Service Industry Trends
  2. 2.2 lncRNA Sequencing Service Industry Drivers
  3. 2.3 lncRNA Sequencing Service Industry Opportunities and Challenges
  4. 2.4 lncRNA Sequencing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global lncRNA Sequencing Service Market Perspective (2021-2032)
  2. 3.2 Global lncRNA Sequencing Service Growth Trends by Region
  3. 3.2.1 Global lncRNA Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global lncRNA Sequencing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global lncRNA Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global lncRNA Sequencing Service Revenue by Players
  2. 4.1.1 Global lncRNA Sequencing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global lncRNA Sequencing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global lncRNA Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global lncRNA Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global lncRNA Sequencing Service Key Players Headquarters & Area Served
  7. 4.4 Global lncRNA Sequencing Service Players, Product Type & Application
  8. 4.5 Global lncRNA Sequencing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global lncRNA Sequencing Service Market CR5 and HHI
  11. 4.6.3 2025 lncRNA Sequencing Service Tier 1, Tier 2, and Tier 3
5 lncRNA Sequencing Service Market Size by Type
  1. 5.1 Global lncRNA Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 5.3 Global lncRNA Sequencing Service Revenue Market Share by Type (2021-2032)
6 lncRNA Sequencing Service Market Size by Application
  1. 6.1 Global lncRNA Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global lncRNA Sequencing Service Revenue by Application (2021-2032)
  3. 6.3 Global lncRNA Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 LC Sciences
  2. 7.1.1 LC Sciences Company Information
  3. 7.1.2 LC Sciences Business Overview
  4. 7.1.3 LC Sciences lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 LC Sciences lncRNA Sequencing Service Product Portfolio
  6. 7.1.5 LC Sciences Recent Developments
  7. 7.2 Creative Biolabs
  8. 7.2.1 Creative Biolabs Company Information
  9. 7.2.2 Creative Biolabs Business Overview
  10. 7.2.3 Creative Biolabs lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative Biolabs lncRNA Sequencing Service Product Portfolio
  12. 7.2.5 Creative Biolabs Recent Developments
  13. 7.3 Eurofins Scientific
  14. 7.3.1 Eurofins Scientific Company Information
  15. 7.3.2 Eurofins Scientific Business Overview
  16. 7.3.3 Eurofins Scientific lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Scientific lncRNA Sequencing Service Product Portfolio
  18. 7.3.5 Eurofins Scientific Recent Developments
  19. 7.4 CD Genomics
  20. 7.4.1 CD Genomics Company Information
  21. 7.4.2 CD Genomics Business Overview
  22. 7.4.3 CD Genomics lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CD Genomics lncRNA Sequencing Service Product Portfolio
  24. 7.4.5 CD Genomics Recent Developments
  25. 7.5 Novogene Co, Ltd.
  26. 7.5.1 Novogene Co, Ltd. Company Information
  27. 7.5.2 Novogene Co, Ltd. Business Overview
  28. 7.5.3 Novogene Co, Ltd. lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novogene Co, Ltd. lncRNA Sequencing Service Product Portfolio
  30. 7.5.5 Novogene Co, Ltd. Recent Developments
  31. 7.6 Beijing Compass Biotechnology Co., Ltd.
  32. 7.6.1 Beijing Compass Biotechnology Co., Ltd. Company Information
  33. 7.6.2 Beijing Compass Biotechnology Co., Ltd. Business Overview
  34. 7.6.3 Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Product Portfolio
  36. 7.6.5 Beijing Compass Biotechnology Co., Ltd. Recent Developments
  37. 7.7 Biomarker Technologies
  38. 7.7.1 Biomarker Technologies Company Information
  39. 7.7.2 Biomarker Technologies Business Overview
  40. 7.7.3 Biomarker Technologies lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biomarker Technologies lncRNA Sequencing Service Product Portfolio
  42. 7.7.5 Biomarker Technologies Recent Developments
  43. 7.8 Azenta
  44. 7.8.1 Azenta Company Information
  45. 7.8.2 Azenta Business Overview
  46. 7.8.3 Azenta lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Azenta lncRNA Sequencing Service Product Portfolio
  48. 7.8.5 Azenta Recent Developments
  49. 7.9 BGI Genomics
  50. 7.9.1 BGI Genomics Company Information
  51. 7.9.2 BGI Genomics Business Overview
  52. 7.9.3 BGI Genomics lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BGI Genomics lncRNA Sequencing Service Product Portfolio
  54. 7.9.5 BGI Genomics Recent Developments
  55. 7.10 Annoroad Gene Technology
  56. 7.10.1 Annoroad Gene Technology Company Information
  57. 7.10.2 Annoroad Gene Technology Business Overview
  58. 7.10.3 Annoroad Gene Technology lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Annoroad Gene Technology lncRNA Sequencing Service Product Portfolio
  60. 7.10.5 Annoroad Gene Technology Recent Developments
8 North America
  1. 8.1 North America lncRNA Sequencing Service Revenue (2021-2032)
  2. 8.2 North America lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America lncRNA Sequencing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America lncRNA Sequencing Service Revenue by Type (2027-2032)
  5. 8.3 North America lncRNA Sequencing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America lncRNA Sequencing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America lncRNA Sequencing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America lncRNA Sequencing Service Revenue by Application (2027-2032)
  9. 8.5 North America lncRNA Sequencing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America lncRNA Sequencing Service Revenue by Country
  11. 8.6.1 North America lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America lncRNA Sequencing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America lncRNA Sequencing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe lncRNA Sequencing Service Revenue (2021-2032)
  2. 9.2 Europe lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe lncRNA Sequencing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe lncRNA Sequencing Service Revenue by Type (2027-2032)
  5. 9.3 Europe lncRNA Sequencing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe lncRNA Sequencing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe lncRNA Sequencing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe lncRNA Sequencing Service Revenue by Application (2027-2032)
  9. 9.5 Europe lncRNA Sequencing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe lncRNA Sequencing Service Revenue by Country
  11. 9.6.1 Europe lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe lncRNA Sequencing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe lncRNA Sequencing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China lncRNA Sequencing Service Revenue (2021-2032)
  2. 10.2 China lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 10.2.1 China lncRNA Sequencing Service Revenue by Type (2021-2026)
  4. 10.2.2 China lncRNA Sequencing Service Revenue by Type (2027-2032)
  5. 10.3 China lncRNA Sequencing Service Revenue Share by Type (2021-2032)
  6. 10.4 China lncRNA Sequencing Service Revenue by Application (2021-2032)
  7. 10.4.1 China lncRNA Sequencing Service Revenue by Application (2021-2026)
  8. 10.4.2 China lncRNA Sequencing Service Revenue by Application (2027-2032)
  9. 10.5 China lncRNA Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia lncRNA Sequencing Service Revenue (2021-2032)
  2. 11.2 Asia lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia lncRNA Sequencing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia lncRNA Sequencing Service Revenue by Type (2027-2032)
  5. 11.3 Asia lncRNA Sequencing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia lncRNA Sequencing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia lncRNA Sequencing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia lncRNA Sequencing Service Revenue by Application (2027-2032)
  9. 11.5 Asia lncRNA Sequencing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia lncRNA Sequencing Service Revenue by Country
  11. 11.6.1 Asia lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia lncRNA Sequencing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia lncRNA Sequencing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA lncRNA Sequencing Service Revenue (2021-2032)
  2. 12.2 SAMEA lncRNA Sequencing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA lncRNA Sequencing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA lncRNA Sequencing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA lncRNA Sequencing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA lncRNA Sequencing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA lncRNA Sequencing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA lncRNA Sequencing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA lncRNA Sequencing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA lncRNA Sequencing Service Revenue by Country
  11. 12.6.1 SAMEA lncRNA Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA lncRNA Sequencing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA lncRNA Sequencing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research